Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA289284
Max Phase: Preclinical
Molecular Formula: C45H56N8O9
Molecular Weight: 852.99
Molecule Type: Small molecule
Associated Items:
ID: ALA289284
Max Phase: Preclinical
Molecular Formula: C45H56N8O9
Molecular Weight: 852.99
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(C(=O)[C@H](CCCCNC(=O)/C=C/c1cccnc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)[C@@H](CC(=O)O)C(=O)N(C)[C@@H](Cc1ccccc1)C(N)=O
Standard InChI: InChI=1S/C45H56N8O9/c1-45(2,3)62-44(61)51-35(25-31-28-49-33-18-10-9-17-32(31)33)41(58)50-34(19-11-12-23-48-38(54)21-20-30-16-13-22-47-27-30)42(59)53(5)37(26-39(55)56)43(60)52(4)36(40(46)57)24-29-14-7-6-8-15-29/h6-10,13-18,20-22,27-28,34-37,49H,11-12,19,23-26H2,1-5H3,(H2,46,57)(H,48,54)(H,50,58)(H,51,61)(H,55,56)/b21-20+/t34-,35?,36-,37-/m0/s1
Standard InChI Key: USWDPRRJNGKNQG-MFRWWEGBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 852.99 | Molecular Weight (Monoisotopic): 852.4170 | AlogP: 3.34 | #Rotatable Bonds: 21 |
Polar Surface Area: 246.22 | Molecular Species: ACID | HBA: 9 | HBD: 6 |
#RO5 Violations: 2 | HBA (Lipinski): 17 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.14 | CX Basic pKa: 4.92 | CX LogP: 1.71 | CX LogD: -0.45 |
Aromatic Rings: 4 | Heavy Atoms: 62 | QED Weighted: 0.05 | Np Likeness Score: -0.11 |
1. Bennett MJ, Nikkel AL, Bianchi BR, Miller TR, Bednarz L, Witte DG, Stashko M, Wang SS, Gore PA, Asin KE.. (1994) CCK-A-selective tetrapeptides containing lys(N epsilon)-amide residues: favorable in vivo and in vitro effects of N-methylation at the aspartyl residue., 37 (11): [PMID:8201591] [10.1021/jm00037a006] |
Source(1):